US Patent Issued to Juno Therapeutics, Memorial Sloan Kettering Cancer Center on Nov. 18 for "Methods for treatment using chimeric antigen receptors specific for B-cell maturation antigen" (Washington, New York Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,345, issued on Nov. 18, was assigned to Juno Therapeutics Inc. (Seattle) and Memorial Sloan Kettering Cancer Center (New York).

"Methods for treatment using chimeric antigen receptors specific for B-cell maturation antigen" was invented by Blythe D. Sather (Seattle), Eric L. Smith (New York), Semih Tareen (Seattle), Aye Chen (Seattle), Cyr De Imus (Seattle), Erik Hess (Seattle), Audrey Olshefsky (Seattle), Stefan Ponko (Seattle) and Mariana Cota Stirner (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are adoptive cell therapy methods involving the administration of doses of cells for treating disease and conditions, including...